{"article_title": "GlaxoSmithKline's Move To Drop Use Of Medical Experts Is Misguided", "article_keywords": ["experts", "medical", "drop", "misguided", "glaxosmithklines"], "article_url": "http://www.forbes.com/sites/johnlamattina/2016/01/11/gsks-move-to-drop-use-of-medical-experts-is-misguided/", "article_text": "", "article_metadata": {"description": "One has to question what real value GSK\u2019s new policy will create.", "author": "John LaMattina", "og": {"site_name": "Forbes", "description": "One has to question what real value GSK\u2019s new policy will create.", "title": "GlaxoSmithKline's Move To Drop Use Of Medical Experts Is Misguided", "url": "http://www.forbes.com/sites/johnlamattina/2016/01/11/gsks-move-to-drop-use-of-medical-experts-is-misguided/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2016-01-11T11:06:19-05:00", "type": "article"}, "twitter": {"description": "One has to question what real value GSK\u2019s new policy will create.", "creator": "@john_lamattina", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "GlaxoSmithKline's Move To Drop Use Of Medical Experts Is Misguided", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Healthcare Innovation,Pharma and Health,Pharma &amp; Healthcare", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2016-01-11", "published": "2016-01-11", "id": "blogAndPostId/blog/post/2009-2377"}, "news_keywords": "Business,Healthcare Innovation,Pharma and Health,Pharma &amp; Healthcare", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}